Mingyi Ju

5PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 01, 2024
Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Mingyi Ju, Jiaojiao Zhang, Zhuoyuan Deng

|Oct 17, 2023
Advancement of anti-LAG-3 in cancer therapy.

Yunong Li, Mingyi Ju, Yuxi Miao

|Oct 28, 2021
A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer.

Mingyi Ju, Longyang Jiang, Qian Wei

|Nov 19, 2020
Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer.

Mingyi Ju, Jia Bi, Qian Wei

|Apr 20, 2020
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.

Mingyi Ju, Aoshuang Qi, Jia Bi

Pageof 1

Frequent Collaborators

1 joint publications

Yunong Li

1 joint publications

Yuxi Miao

1 joint publications

Lin Zhao

1 joint publications

Lijuan Xing